在外科手术期间暴露于德克斯梅托米丁与移植后脏结果之间的关联:回顾性分析
Kuo-Chuan Hung1,2, Ting-Sian Yu3, Chun-Ning Ho1,2
1Department of Anesthesiology, Chi Mei Medical Center, Tainan City, Taiwan.
Drug design, development and therapy
|March 3, 2026
概括
在移植接受者中,外科术期间使用德克斯梅德托米丁与较少的早期并发症有关,如延迟的移植功能,急性排斥和移植失败. 需要进一步的研究来证实这些发现的移植结果.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 麻醉学 麻醉学
- 移植手术 移植手术
背景情况:
- 延迟移植功能 (DGF) 是移植后的一个主要并发症,影响患者的治疗结果和医疗费用.
- 了解缓解DGF并改善移植存活的因素对于优化移植方案至关重要.
研究的目的:
- 为了研究移植受体中术前德克斯梅德托米丁暴露和术后结果之间的关联.
- 评估德克斯梅德托米丁对DGF的影响,急性排斥,移植失败,感染,死亡率和估计的膜过率 (eGFR).
主要方法:
- 使用TriNetX研究网络 (2014年1月至2024年12月) 进行的回顾性队列研究.
- 成年移植接受者因手术内暴露于德克斯梅德米丁而分层.
- 倾向性得分匹配用于创建可比的队列 (每组3366名患者).
主要成果:
- 德克斯梅德托米丁暴露与七天后DGF的显著较低率相关 (OR 0.86,p=0.009).
- 在使用德克斯梅托米丁时观察到急性排斥 (OR 0.34,p<0.001) 和移植失败 (OR 0.42,p<0.001) 的发生率降低.
- 这些好处持续了30天,但随着时间的推移而减弱;没有发现感染,死亡率或eGFR的显著差异.
结论:
- 术内使用德克斯梅德托米丁可以减少移植后的早期并发症.
- 这项研究的观察性质要求谨慎;需要随机对照试验来确定因果关系.
- 德克斯梅德托米丁 (Dexmedetomidine) 显示出作为辅助疗法的潜力,以改善移植中早期移植结果.
相关概念视频
01:26Kidney Transplant II: Surgical Procedure
579
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
579
01:16Kidney Transplant III: Nursing Management
466
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
466
01:28Kidney Transplant I: Introduction
600
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
600
01:26Pharmacokinetic–Pharmacodynamic Relationship: Exposure, Response and Effect
93
The pharmacokinetic-pharmacodynamic (PK-PD) relationship describes the intricate link between drug exposure, efficacy, and toxicity, forming the foundation for optimal dosing regimens. This relationship uses mathematical modeling to characterize drug concentration-effect dynamics, ensuring precise therapeutic outcomes.Exposure represents the pharmacokinetic aspect of the PK-PD relationship, denoting the drug amount that elicits a biological response. It is typically quantified by administered...
93
01:25Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
285
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
285
01:24Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
317
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
317